GUSTAVO Adolfo HERESI DAVILA
Works at
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
UH3, 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension, UH3HL175041, 2024–2030, Aug 24, 2026
National Heart, Lung, and Blood Institute
UG3, 1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension, UG3HL175041, 2024–2025, Sep 1, 2024
Sources: reporter.nih.gov